Georgia Kaiafa | Clinical Neuroscience | Best Researcher Award

Published on by Neuroscientists

Assoc. Prof. Dr. Georgia Kaiafa | Clinical Neuroscience | Best Researcher Award

Assoc. Prof. Dr. Georgia Kaiafa, Medical School, Aristotle University of Thessaloniki,  Greece.

Dr. Georgia Kaiafa is a distinguished hematologist and academician whose career spans clinical excellence, impactful research, and dedicated teaching. A graduate of Aristotle University of Thessaloniki, she earned her MBBS in 1987, Board Certification in Hematology in 1996, and completed her Doctorate in 2005. Her academic roles have progressed from Lecturer to Associate Professor of Hematology and Thromboembolic Diseases, with a longstanding association at AHEPA University Hospital.

Profile

Scopus

 

🎓 Early Academic Pursuits

Georgia Kaiafa began her academic journey in medicine at the prestigious Aristotle University of Thessaloniki, enrolling in the Medical School in 1980. Her foundational training was marked by determination and intellectual rigor, culminating in the completion of her MBBS in 1987. A steadfast commitment to advanced education led her to earn her Board Certification in Haematology by 1996, and later, she successfully defended her Doctorate thesis in 2005. These formative years reflect her deep-rooted passion for understanding hematological science and its clinical applications.

🧬 Professional Endeavors in Hematology

Her professional journey has been nothing short of inspiring, anchored in both clinical excellence and academic growth. Georgia Kaiafa has served in several academic ranks, beginning as a Lecturer in Hematology from 2007 to 2015, advancing to Assistant Professor until 2021, and currently holding the esteemed position of Associate Professor of Hematology and Thromboembolic Diseases. She is affiliated with AHEPA University Hospital’s Hematology Department, a major center of excellence in Greece. Her expertise was further enriched by her tenure as a Visiting Research Associate at King’s College Hospital in London in 2012, where she gained valuable international exposure. Since 2005, she has also played a leadership role as a Coordinator in the Northern Greece Office of the Health Sector, bridging academic medicine and healthcare policy.

🩸 Contributions and Research Focus

Georgia Kaiafa has devoted her scholarly efforts to advancing the understanding of thrombosis, thromboembolic disorders, and hematological malignancies. With her contributions to over 95 peer-reviewed international journal publications and participation as a Principal Investigator in 26 research trials, she has carved out a niche in evidence-based hematological research. Her investigations have deeply influenced protocols and practices in vascular pharmacology, hematologic diagnostics, and the clinical management of thrombotic conditions. She is also a prominent educator, mentoring Ph.D. candidates and contributing to postgraduate programs for both Greek and international students.

🏆 Accolades and Recognition

Her scientific contributions have not gone unnoticed. Georgia Kaiafa has received significant national acclaim, including the 1st Prize Award for Best Paper at the Pan-Hellenic Haematology Conference in 2008 and again at the 1st Conference of Internal Medicine of Northern Greece in 2015. These accolades affirm her research excellence and clinical insight. Her expertise has earned her memberships in elite national and international medical societies, including the Hellenic Stroke Organization and the European Stroke Organization, as well as a respected position in the Excellence of Thrombosis initiative.

🌍 Impact and Influence

Beyond academia and clinical service, Kaiafa has exerted influence on multiple scientific fronts. As a reviewer for prominent journals such as Thrombosis Research, Anemia, Case Reports in Hematology, and the Indian Heart Journal, she ensures high scientific standards in hematologic research worldwide. Her editorial work for both international and Greek journals demonstrates her authority in the field and her dedication to the progression of scientific communication. Her wide-ranging collaborations and committee leadership roles have significantly influenced health education and medical research in Greece and abroad.

📚 Scholarly Engagement and Mentorship

Georgia Kaiafa is not only a prolific researcher but also a passionate mentor and academic contributor. With 23 chapters in medical books, over 130 abstracts in Greek conference proceedings, and nearly 100 abstracts presented in international forums, her voice resonates across the global hematology community. She has mentored and supervised numerous doctoral students, serving on committees for 12 Ph.D. projects and directly supervising five, cultivating the next generation of scientific minds. She has also chaired 22 congress sessions and delivered more than 100 invited talks, emphasizing her respected role as both speaker and thought leader.

🔬 Legacy and Future Contributions

As a seasoned academic and clinical researcher, Georgia Kaiafa continues to shape the future of hematology in Greece and beyond. Her legacy lies in her dual commitment to clinical care and scientific discovery, especially in the realm of thromboembolic diseases and hematologic innovations. Her ongoing involvement in research protocols, editorial responsibilities, and student mentorship assures that her influence will persist. With a solid foundation and a career marked by excellence, her future contributions are likely to further impact hematological sciences and translational medicine globally.

publication

 

  • Title: Monocyte Chemoattractant Protein-1 as a Biomarker in Acute Ischemic Stroke: A Prospective Pilot Study
    Author(s): [Not specified]
    Year: 2025

 

  • Title: Prospective Study of ADAMTS13 and von Willebrand Factor’s Role in the Prediction of Outcomes in Acute Ischemic Stroke
    Author(s): [Not specified]
    Year: 2025

 

  • Title: Antiphospholipid Syndrome: A Comprehensive Clinical Review
    Author(s): [Not specified]
    Year: [Not specified]

 

  • Title: The Seasonal Distribution of Immune Thrombotic Thrombocytopenic Purpura is Influenced by Geography: Epidemiologic Findings from a Multi-Center Analysis of 719 Disease Episodes
    Author(s): [Not specified]
    Year: 2024

 

  • Title: Current Trends in Stroke Biomarkers: The Prognostic Role of S100 Calcium-Binding Protein B and Glial Fibrillary Acidic Protein
    Author(s): [Not specified]
    Year: [Not specified]

 

  • Title: Outpatient Management After Hospitalisation for Acute Decompensation of Cirrhosis: A Practical Guide
    Author(s): [Not specified]
    Year: 2024

 

  • Title: Which Is the Best Way to Treat Massive Hemoptysis? A Systematic Review and Meta-Analysis of Observational Studies
    Author(s): [Not specified]
    Year: [Not specified]

 

  • Title: Post-COVID-19 and Irritable Bowel Syndrome: A Literature Review
    Author(s): [Not specified]
    Year: [Not specified]

 

  • Title: Thyroid Disease and Systemic Lupus Erythematosus
    Author(s): [Not specified]
    Year: 2023

 

🏁 Conclusion

Dr. Georgia Kaiafa embodies the values of academic integrity, scientific advancement, and clinical leadership. Her commitment to both national healthcare development and international scientific collaboration sets her apart. With a strong foundation in research, education, and public health, she not only meets but exceeds the criteria for recognition through the Best Researcher Award. Her body of work stands as a testament to sustained excellence and future promise in hematology and related disciplines.

ROSA MOURAO | Neuropharmacology | Women Researcher Award

Published on by Neuroscientists

Prof. Dr. ROSA MOURAO | Neuropharmacology | Women Researcher Award

Prof. Dr. ROSA MOURAO, UNIVERSIDADES FEDERAL DO OESTE DO PARÁ, Brazil.

Prof. Dr. Rosa Helena Veras Mourão is a distinguished Brazilian biochemist and full professor at UFOPA, with a strong academic foundation in Biological Sciences and Plant Biochemistry. She earned her Ph.D. in Biological Sciences from the Federal University of Pernambuco, including a research fellowship at UNICAMP under Prof. Dr. Mário Saad. Her research centers on the biochemical properties of Amazonian medicinal plants, focusing on diabetes, anti-inflammatory and antimicrobial activities, essential oils, and the effects of Bothrops atrox venom.

Profile

Orcid

🎓 Early Academic Pursuits

Rosa Helena Veras Mourão embarked on her scientific journey with a Bachelor’s degree in Biological Sciences from the Federal University of Ceará in 1993. Her early academic choices reflected a deep curiosity about the natural world, especially the biochemical aspects of plant life. She soon pursued a Master’s degree in Plant Biochemistry at the same institution, which she completed in 1996. Her growing interest in health-related plant biochemistry led her to a doctoral program in Biological Sciences at the Federal University of Pernambuco, awarded in 2006. During her Ph.D., she was selected for a prestigious sandwich fellowship at the State University of Campinas (UNICAMP), where she conducted research under the guidance of Prof. Dr. Mário Saad, further sharpening her expertise in metabolic disorders like diabetes.

🧪 Professional Endeavors in Biochemistry

Currently a Full Professor at the Institute of Collective Health at the Federal University of Western Pará (UFOPA), Prof. Mourão has built a solid career blending academic research with community outreach. Her expertise lies in Biochemistry, particularly medicinal plants and their applications in treating chronic diseases. Her work consistently merges scientific rigor with social relevance, focusing on diabetes, antimicrobial resistance, anti-inflammatory responses, and the effects of Bothrops atrox venom. She has mentored numerous Master’s students through UFOPA’s Health Sciences and Natural Resources programs and also advises Ph.D. candidates under the REDE BIONORTE initiative, reflecting her pivotal role in academic mentorship and capacity building in the Amazon region.

🌿 Contributions and Research Focus

Prof. Mourão’s research delves into the pharmacological potential of Amazonian flora, particularly essential oils and plant extracts with therapeutic effects. Her contributions include advancing the standardization of bioactive extracts, evaluating their antimicrobial and anti-inflammatory properties, and assessing their applicability in the treatment of diabetes. Her scientific investigations into Bothrops atrox venom have added critical insights to toxinology. Furthermore, her interdisciplinary approach bridges biochemistry with ethnopharmacology, respecting traditional knowledge systems while applying rigorous scientific methods to validate their efficacy.

🏅 Accolades and Recognition

Her commitment to research excellence earned her the prestigious CNPq Research Productivity Fellowship (PQ2), which she held until 2023. This national recognition highlighted her sustained contributions to Brazilian science, particularly in the fields of medicinal chemistry and natural products. In academic circles, her name appears under various bibliographic formats such as MOURÃO, R.H.V. and Rosa H. Mourão, indicating her prolific and diverse scholarly output. She is also active on national platforms such as the Lattes Curriculum system and holds an ORCID iD, further ensuring her work’s visibility and impact within global research communities.

🌎 Impact and Social Innovation

Beyond academia, Prof. Mourão is deeply involved in projects that fuse scientific knowledge with social innovation. She co-founded Deveras Amazônia, a startup that transforms Amazonian biodiversity into culinary experiences, and Xibé Oficial, a fashion-focused enterprise using natural dyes extracted from Amazonian plants. Her technological extension projects with local communities in Western Pará demonstrate her commitment to applying scientific research for social impact, focusing on sustainable development and strengthening regional production chains. Her work empowers Amazonian communities by integrating traditional knowledge with entrepreneurial strategies.

🔬 Legacy in Scientific Mentorship

Throughout her academic career, Prof. Mourão has mentored a generation of scientists who now contribute to fields as diverse as biochemistry, pharmacognosy, and public health. As a Master’s and Ph.D. advisor, she fosters critical thinking, innovation, and social responsibility in her students. Her guidance helps shape professionals capable of addressing both local health challenges and broader scientific questions. Her legacy lies not only in her publications and projects but also in the human capital she has developed over decades of service.

🌱 Future Contributions and Vision

Looking ahead, Prof. Rosa Helena Veras Mourão remains a beacon of interdisciplinary research in the Amazon. Her vision includes expanding collaborations that promote bioeconomic development rooted in sustainability, enhancing the integration of indigenous knowledge systems into mainstream science, and scaling up social-impact projects. With her strong academic foundation and unwavering dedication to public health and biodiversity, she continues to serve as an inspiring force in Brazilian science, forging a future where innovation, ecology, and equity go hand in hand.

Publication

1. Antifungal chemosensitization through induction of oxidative stress: A model for control of candidiasis based on the Lippia origanoides essential oil
Authors: Sandra Layse F. Sarrazin, Jean-Paul Bourdineaud, José Guilherme S. Maia, Rosa Helena V. Mourão, Ricardo B. Oliveira
Year: 2024

2. Lip balm made from butter extracted from bacuri (Platonia insignis Mart.) Amazonian fruit seeds: Development and characterization
Authors: Bruna Carvalho Cantal de Souza, Walberson da Silva Reatgui, Junior Avelino de Araújo, Rosa Helena Veras Mourão, Leopoldo C. Baratto, Gabriela B. dos Santos, Kariane M. Nunes
Year: 2024

3. Volatile Constituents of Some Myrtaceous Edible and Medicinal Fruits from the Brazilian Amazon
Authors: Adenilson S. Barroso, Lais T. Massing, Chieno Suemitsu, Rosa Helena V. Mourão, Pablo L. B. Figueiredo, José Guilherme S. Maia
Year: 2024

4. Molecular modelling and anticholinesterase activity of the essential oil from three chemotypes of Lippia alba (Mill.)
Authors: Antônio Q. Silva Júnior, Gabriela dos Santos Rodrigues, Karina A. de Sousa, Leoneide E. M. Bouillet, Gabriela B. dos Santos, Adenilson S. Barroso, Rosa Helena Veras Mourão
Year: 2024

5. Seasonal Variation in Essential Oil Composition and Antioxidant Capacity of Aniba canelilla
Authors: Ellen de Nazaré S. da Cruz, Luana de Sousa P. Barros, Bruna de Araújo Guimarães, Rosa Helena V. Mourão, José Guilherme S. Maia, William N. Setzer, Joyce Kelly da Silva, Pablo L. B. Figueiredo
Year: 2023

6. Distribution of Carapa Guianensis Associated to Topoclimatic Variables Indicating Potential Clusters for Cultivation in the State of Pará
Authors: Denison Lima Correa, Lucieta G. Martorano, Leila Sheila S. Lisboa, Carlos T. dos S. Dias, Alberdan S. Santos, Rosa Helena V. Mourão
Year: 2023

7. Seasonal Influence on Volatile Composition of Psidium friedrichsthalianum Leaves, Sampled in the Brazilian Amazon
Authors: Paulo V. L. Santos, Ellen de N. S. da Cruz, Jennifer de A. Nunes, Rosa Helena V. Mourão, Walnice M. O. do Nascimento, José Guilherme S. Maia, Pablo L. B. Figueiredo
Year: 2023

8. Seasonal Variability of a Caryophyllane Chemotype Essential Oil of Eugenia patrisii Vahl Occurring in the Brazilian Amazon
Authors: Ellen de N. S. da Cruz, Luana de S. Peixoto, Jamile S. da Costa, Rosa Helena V. Mourão, Walnice M. O. do Nascimento, José Guilherme S. Maia, William N. Setzer, Joyce Kelly da Silva, Pablo L. B. Figueiredo
Year: 2022

9. Atividade antioxidante de extratos de Myrciaria dubia (camu-camu)
Authors: Carlena Sinara M. da Silva, Rosa Helena Veras Mourão
Year: 2022

10. Myrciaria dubia (Kunth) McVaugh (Myrtales: Myrtaceae): análise dos produtos elaborados a partir do seu fruto
Authors: Carlena Sinara M. da Silva, Rosa Helena Veras
Year: 2021

🧾 Conclusion

Prof. Rosa Helena Veras Mourão exemplifies a modern scientist whose work harmonizes rigorous biochemical research with social and environmental impact. Her commitment to advancing science in the Amazon, empowering communities, and nurturing future scholars positions her as a transformative figure in Brazilian research. Her legacy is defined not only by academic excellence but also by her visionary efforts to blend innovation with inclusivity, ensuring that science serves both nature and society.

Ged Smith | Systems Neuroscience | Outstanding Educator Award

Published on by Neuroscientists

Dr. Ged Smith | Systems Neuroscience | Outstanding Educator Award

Dr. Ged Smith,  UK AFT, United Kingdom.

Dr. Ged Smith is a highly esteemed Consultant Systemic/Family and Couples Psychotherapist with over 25 years of experience in clinical practice, academic teaching, and international consultation. His early academic journey began with a B.Ed from Liverpool University, followed by advanced degrees culminating in a Professional Doctorate from Birkbeck University and the Institute of Family Therapy. Throughout his career, Dr. Smith has made influential contributions through clinical supervision, research publication, and educational leadership. He is widely published in top-tier journals and is the longstanding Editor of “Context,” the UK’s principal family therapy journal. He also holds senior roles in professional organizations such as the Association for Family Therapy (AFT) and the European Family Therapy Association (EFTA). Dr. Smith’s work bridges therapeutic practice with systemic theory, making significant impact on the field both nationally and internationally.

Profile

Orcid

🎓 Early Academic Pursuits

Dr. Ged Smith began his academic journey at Liverpool University, where he earned his Bachelor of Education (B.Ed) in 1980, laying the foundation for a lifelong dedication to learning and teaching. His growing interest in social care and mental health led him to pursue a Certificate of Qualification in Social Work (CQSW) at the University of Cardiff, which he completed in 1988. Deepening his expertise in systemic practices, Dr. Smith undertook a Master of Science (MSc) in collaboration with the Institute of Family Therapy (IFT) and Birkbeck University, London in 1996. His academic excellence culminated in the attainment of a Professional Doctorate from the same institutions in 2011, solidifying his scholarly contributions to systemic and family therapy.

🧠 Professional Endeavors in Systemic Therapy

Dr. Smith’s career spans over 25 years of clinical experience in both Merseyside and London, where he has provided systemic and family therapy across diverse communities. As a UKCP Registered Systemic Psychotherapist and AFT Accredited Supervisor, he currently supervises more than 30 mental health and social care professionals. His professional influence extends across clinical settings, educational platforms, and governmental agencies, making him a sought-after consultant for Social Services and Care Agencies in the North West of England. His dedication to systemic thinking is evident in his role as a Live Supervisor on the Manchester Family Therapy Qualifying Course, where he brings practical and ethical insight to emerging therapists.

📝 Contributions and Research Focus

Dr. Smith has been an unwavering contributor to the dissemination of systemic knowledge, both as a prolific writer and respected editor. As the long-standing Editor of “Context,” the UK’s leading Family Therapy Journal, he has significantly influenced the field’s intellectual discourse. His research focus centers on transformative and relational practices in systemic therapy, engaging with contemporary themes in mental health. His published work appears in globally respected journals such as the Journal of Family Therapy, Family Process (USA), Human Systems, and the Australian and New Zealand Journal of Family Therapy. Notably, he contributed chapters to Systemic Therapy as Transformative Practice (2017), reflecting his commitment to therapeutic innovation and social justice.

📚 Academic Leadership and Teaching Excellence

Dr. Smith has played a vital role in academic mentorship and systemic education. A revered Visiting Lecturer at the Tavistock Clinic London, and universities including Manchester, Exeter, and Hull, he continues to influence systemic thinking across academic and clinical boundaries. In his role as an External Doctoral Supervisor at the University of Bedfordshire, he nurtures the next generation of systemic scholars. His expertise in integrating theory with practice has made him a preferred speaker and educator at family therapy training courses throughout the UK.

🏆 Accolades and Recognition

Dr. Smith’s long-standing contributions to systemic therapy have earned him national and international recognition. As Chair of AFT Publishing for over 20 years, he has guided the ethical and academic standards of family therapy literature in the UK. He also represents the UK at the European Family Therapy Association (EFTA) meetings, further elevating the UK’s presence on the global systemic stage. His respected status in the field is not only a result of his academic output but also his unwavering dedication to supervision, teaching, and ethical therapeutic practice.

🌍 Global Engagement and Influence

A distinguished conference speaker and workshop presenter, Dr. Smith has shared his insights on systemic and psychological approaches to mental health at international platforms. His presentations emphasize both clinical depth and sociocultural relevance, addressing topics like family systems, relational ethics, and collaborative practices in therapy. By integrating global perspectives into his work, Dr. Smith continues to expand the reach and relevance of systemic psychotherapy.

🧬 Legacy and Future Contributions

Dr. Ged Smith’s career represents a profound legacy of relational practice, scholarly excellence, and ethical leadership. As systemic therapy continues to evolve in response to modern challenges, his work sets a benchmark for future generations. With his continued supervision of doctoral candidates, editorial leadership, and international teaching, he remains at the forefront of shaping the future of family therapy. His vision is clear: to maintain systemic practice as not only a clinical method but a transformative social discourse that can empower families, communities, and practitioners alike.

Publication

  • Title: So, You’re Doing a Family Therapy Course……
    Author: Ged Smith
    Year: 2025

 

  • Title: A 1.5‐Order Therapy: Between Knowing and Not‐Knowing
    Author: Ged Smith
    Year: 2023

 

✅ Conclusion

Dr. Ged Smith exemplifies excellence in systemic and family psychotherapy through a unique blend of scholarly depth, clinical wisdom, and passionate teaching. His enduring influence on the development of family therapy—through publications, supervision, and organizational leadership—makes him a key figure in shaping contemporary mental health practices. As a researcher, educator, and clinician, he has created a meaningful legacy grounded in relational ethics and transformative therapeutic approaches. Dr. Smith’s continued contributions will undoubtedly inspire future practitioners and scholars committed to holistic, systemic care.

Joice Margareth de Almeida Rodolpho | Molecular Neuroscience | Best Researcher Award

Published on by Neuroscientists

Mrs. Joice Margareth de Almeida Rodolpho | Molecular Neuroscience | Best Researcher Award

Mrs. Joice Margareth de Almeida Rodolpho, Universidade Federal de São Carlos, Brazil.

Joice Margareth de Almeida Rodolpho is a dedicated Brazilian researcher with a strong foundation in biotechnology, parasitology, immunology, and molecular biology. She earned her Master’s and Ph.D. from the Federal University of São Carlos (UFSCar), where she explored the role of eosinophils as antigen-presenting cells in parasitic infections like Toxocara canis and Schistosoma mansoni. Her work is recognized for integrating experimental immunology with therapeutic innovations, such as the evaluation of natural plant extracts and nanomaterials for infection control. She further specialized in Flow Cytometry and Oncohematology, enhancing her analytical capabilities. With multiple awards and citations, her impactful contributions continue to strengthen Brazil’s standing in parasitological and immunological research.

Profile

Orcid

🎓 Early Academic Pursuits

Joice Margareth de Almeida Rodolpho began her academic journey in Brazil, developing a strong foundation in the life sciences. Her early interest in molecular biology and parasitology led her to pursue advanced studies at the esteemed Universidade Federal de São Carlos (UFSCar). She earned her Master’s degree in Biotechnology between 2009 and 2012, conducting significant research on Toxocara canis, particularly on the phenotypic characterization of eosinophils as antigen-presenting cells. This early work not only revealed her meticulous scientific inquiry but also laid the groundwork for her deeper exploration into immunology.

🧬 Professional Endeavors in Molecular and Evolutionary Genetics

Driven by a passion for understanding immune responses, Joice pursued a Ph.D. in Evolutionary Genetics and Molecular Biology at UFSCar from 2013 to 2017. Her doctoral research focused on the role of eosinophils as antigen-presenting cells both in vitro and ex vivo, offering vital insights into host-parasite interactions and immune regulation. Her work during this period was supported by a prestigious FAPESP scholarship, demonstrating her academic excellence and the relevance of her contributions. Under the mentorship of Professor Fernanda de Freitas Anibal, Joice refined her skills in experimental immunology and cellular biology.

🧪 Contributions and Research Focus in Parasitology and Immunopathology

Joice Rodolpho’s primary research interests lie at the intersection of parasitology, cellular immunology, and experimental pathology. Her studies explore how parasitic infections, such as those caused by Schistosoma mansoni and Toxocara canis, affect immune cell function, especially eosinophils. She has also contributed to investigations into natural plant extracts, like Mentha piperita L., assessing their therapeutic potential in modulating parasitic infections. Moreover, she extended her expertise to the field of nanomaterials, evaluating the cytotoxicity and cell death mechanisms induced by compounds like Ag₂WO₄, thus bridging classical parasitology with emerging biomedical technologies.

🏅 Accolades and Recognition in Scientific Circles

Throughout her career, Joice has received several recognitions that reflect the impact and originality of her research. In 2010, she was honored with a Menção Honrosa (Honorable Mention) for her work on Mentha piperita L. in treating Schistosoma mansoni, earning 2nd place in diagnostics and treatment. She continued to gain academic acclaim with awards at major conferences, including the VI Congresso da Sociedade Paulista de Parasitologia (2012) and the XXII B-MRS Meeting in 2024, highlighting her work on cytotoxic responses and innovative parasitological control methods. In 2024, her project on the parasitological and pathological evaluation of AW-HRL-C for schistosomiasis control was notably recognized by UNIFESP.

🧠 Impact and Influence in Experimental Immunology

Joice’s dedication to experimental immunology and cytometry has allowed her to mentor and influence upcoming researchers, especially in specialized fields such as flow cytometry. Her recent specialization in Immunology and Oncohematology by Flow Cytometry (2021–2022) at IPESSP further enriched her profile, showcasing her commitment to continuous learning and application of advanced technologies in immune profiling. Her ability to merge classical immunopathology with state-of-the-art cytometric tools reflects her versatility and forward-thinking scientific approach.

🌱 Legacy and Future Contributions in Biomedical Science

Poised to make lasting contributions, Joice Margareth de Almeida Rodolpho stands at the forefront of research into host-pathogen interactions, parasitic disease management, and immune cell function modulation. Her unique interdisciplinary approach—integrating molecular biology, natural product pharmacology, and immunological techniques—positions her as a valuable contributor to both academic research and potential therapeutic advancements. She is expected to lead innovative research in the treatment of neglected tropical diseases and immunological disorders, with implications for global health.

🔬 Research Field Relevance and Scientific Identity

As a scholar deeply embedded in the Brazilian scientific ecosystem, Joice’s identity is reflected in her multiple citation forms, indicating her widespread academic collaborations and international visibility. Her expertise bridges evolutionary genetics, biotechnology, cytometry, and immunoparasitology—making her a multifaceted researcher. Her contributions are cited under various names such as “RODOLPHO, JOICE M. A.” and “Joice Margareth de Almeida Rodolpho,” reflecting a robust presence in scholarly literature and ensuring her work continues to guide parasitological and immunological research for years to come.

Publication

  • Title: Biomarkers and Mental Disorders: A Relevance Analysis Using a Random Forest Algorithm
    Authors: Joice M. A. Rodolpho; Krissia F. Godoy; Bruna D. L. Fragelli; Jaqueline Bianchi; et al.
    Year: 2025

 

  • Title: Death Risk Score Model of Hospitalized COVID‐19 Patients: A Cohort Study
    Authors: Gustavo A. Cruz; Thais B. Boteon; Henrique Pott; Joice M. A. Rodolpho; et al.
    Year: 2025

 

  • Title: Synergistic Antifungal Effect and In Vivo Toxicity of a Monoterpene Isoespintanol Obtained from Oxandra xylopioides Diels
    Authors: Orfa I. C. Martínez; Alberto Angulo; Joice Rodolpho; Krissia F. Godoy; et al.
    Year: 2024

 

  • Title: Synergistic Antifungal Effect and In Vivo Toxicity of the Monoterpene Isoespintanol Obtained from Oxandra xylopioides Diels (Preprint)
    Authors: Orfa I. C. Martínez; Alberto Angulo; Joice M. A. Rodolpho; et al.
    Year: 2024

 

  • Title: Carbon Black CB-EDA Nanoparticles in Macrophages: Changes in the Oxidative Stress Pathway and in Apoptosis Signaling
    Authors: Joice M. A. Rodolpho; Krissia F. Godoy; Bruna D. L. Fragelli; et al.
    Year: 2023

 

  • Title: HGPRT and PNP: Recombinant Enzymes from Schistosoma mansoni and Their Role in Immunotherapy during Experimental Murine Schistosomiasis
    Authors: Bruna D. L. Fragelli; Ana C. Fattori; Joice M. A. Rodolpho; et al.
    Year: 2023

 

  • Title: Titanium Dioxide Nanoparticle (TiO2 NP) Induces Toxic Effects on LA-9 Mouse Fibroblast Cell Line
    Authors: Ana C. M. Fattori; Patricia Brassolatti; Joice M. A. Rodolpho; et al.
    Year: 2023

 

  • Title: Analysis of Cytotoxicity and Genotoxicity in a Short-Term Dependent Manner Induced by a New Titanium Dioxide Nanoparticle in Murine Fibroblast Cells
    Authors: Pedrino, M.; Brassolatti, P.; Joice M. A. Rodolpho; et al.
    Year: 2022

 

  • Title: Functionalized Titanium Nanoparticles Induce Oxidative Stress and Cell Death in Human Skin Cells
    Authors: Brassolatti, P.; Joice M. A. Rodolpho; Krissia F. Godoy; et al.
    Year: 2022

 

  • Title: Toxicological Effects of the Mixed Iron Oxide Nanoparticle (Fe₃O₄ NP) on Murine Fibroblasts LA-9
    Authors: Alves Feitosa, K.; Joice M. A. Rodolpho; et al.
    Year: 2022

 

🧾 Conclusion

Joice Rodolpho’s academic journey and scientific contributions reveal a researcher of high caliber, committed to advancing our understanding of host-pathogen dynamics and immune system function. Her work, grounded in rigorous experimentation and innovation, holds promise for developing novel therapies for neglected tropical diseases. With a forward-looking approach and interdisciplinary expertise, she stands out as a key contributor in biomedical science, poised to influence future discoveries in immunopathology and disease control.

Ivan Zivotic | Molecular Neuroscience | Best Researcher Award

Published on by Neuroscientists

Dr. Ivan Zivotic | Molecular Neuroscience | Best Researcher Award

Dr. Ivan Zivotic, Vinča Institute of Nuclear Sciences, University of Belgrade, Serbia.

Dr. Ivan Životić is a Serbian molecular geneticist whose research focuses on the genetic epidemiology of complex human diseases such as atherosclerosis, congenital kidney anomalies, and chronic inflammatory conditions. With a Ph.D. in Molecular Biology from the University of Belgrade and a master’s background in applied genetics, he has cultivated a strong academic and research foundation. Currently affiliated with the “Vinča” Institute of Nuclear Sciences, he has authored 16 scientific papers and coauthored over 40 abstracts, contributing meaningfully to the fields of genomics and transcriptomics. His expertise lies in deciphering gene-disease associations using modern molecular and computational tools.

Profile

Orcid

🎓 Early Academic Pursuits

Born on July 23, 1986, in Belgrade, Serbia, Dr. Ivan Životić embarked on a promising academic journey rooted in the life sciences. His passion for unraveling the genetic underpinnings of human diseases led him to the Faculty of Biology at the University of Belgrade. He obtained a Master’s degree in Molecular Biology and Physiology in 2011, specializing in applied genetics within the Department of Population Genetics. His master’s thesis explored the role of GST M1 and GST T1 gene deletion polymorphisms in multiple sclerosis, laying the groundwork for his deep engagement in genetic epidemiology. He continued with doctoral studies at the same faculty, where he focused on the molecular biology of eukaryotes. His Ph.D. thesis examined the association between genetic variants on chromosome 9p21 and transcription levels of CDKN2B and HACD4 genes with atherosclerosis and its complications, graduating with an impressive average grade of 9.7.

🧬 Research Focus in Molecular Genetics

Dr. Životić’s research is rooted in molecular genetics with a core focus on the genetic epidemiology of complex human diseases. His scientific curiosity revolves around how genomic and transcriptomic profiles contribute to the development of conditions such as atherosclerosis, congenital kidney anomalies, and chronic inflammatory diseases. His work integrates molecular tools and population studies to understand genetic variants and their influence on disease onset, making valuable contributions to the broader fields of genomics and transcriptomics. His dedication to uncovering genetic risk factors reflects a commitment to improving predictive medicine and tailored healthcare strategies.

🏥 Professional Endeavors in Medical Sciences

Professionally, Dr. Životić holds a distinguished position at the “Vinča” Institute of Nuclear Sciences, a leading Serbian national research institute affiliated with the University of Belgrade. His role within this multidisciplinary environment places him at the forefront of translational research, bridging the gap between laboratory discoveries and clinical applications. Collaborating with esteemed researchers and clinicians, he continually advances the understanding of how molecular mechanisms translate into disease phenotypes, particularly within the realm of cardiovascular and renal health.

📚 Contributions to Scientific Literature

Dr. Životić has authored 16 research papers in internationally recognized SCI journals and coauthored over 40 scientific abstracts presented at prestigious conferences. These publications represent his steady and thoughtful contributions to the academic community. His scholarly output reflects not only the depth of his investigations but also his role in team-based science. His Scopus-indexed h-index of 4 and 54 heterocitations (as of February 12, 2025) demonstrate a growing influence in the field of molecular medical research.

🏆 Accolades and Academic Recognition

Dr. Životić’s academic achievements are complemented by consistent scholarly excellence. With high average grades throughout his university education and a commendable Ph.D. thesis addressing significant clinical concerns, he has earned recognition within his academic circles. His scientific insights into cardiovascular genomics have positioned him as a promising voice among early-career researchers in Serbia’s biomedical community. His educational accomplishments, including supervision under renowned expert Dr. Maja Živković, reflect a foundation built on rigor and mentorship.

🌍 Scientific Impact and Global Relevance

The research conducted by Dr. Životić holds substantial relevance not only within Serbia but also internationally, given the global burden of atherosclerosis and other complex diseases. His work on gene expression, chromosomal variations, and their clinical correlations contributes to a better understanding of disease mechanisms that affect millions worldwide. His interdisciplinary approach, blending genetics, epidemiology, and bioinformatics, is increasingly critical for the development of precision medicine.

🔬 Legacy and Future Contributions

Looking forward, Dr. Životić is poised to make further breakthroughs in the fields of medical genomics and complex disease genetics. As the need for personalized medicine grows, his contributions are expected to inform diagnostic and therapeutic approaches that are tailored to individual genetic backgrounds. With a strong foundation, a collaborative research spirit, and an unwavering focus on human health, Dr. Životić is building a scientific legacy that will inspire future generations of geneticists and medical researchers.

Publication

  • Title: Expression of HMGB1, TGF-β1, BIRC3, ADAM17, CDKN1A, and FTO in Relation to Left Ventricular Remodeling in Patients Six Months after the First Myocardial Infarction: A Prospective Study
    Authors: Jovana Kuveljic, Ana Djordjevic, Ivan Zivotic, Milica Dekleva, Ana Kolakovic, Maja Zivkovic, Aleksandra Stankovic, Tamara Djuric
    Year: 2024

 

  • Title: Gene expression of chemokines CX3CL1 and CXCL16 and their receptors, CX3CR1 and CXCR6, in peripheral blood mononuclear cells of patients with relapsing-remitting multiple sclerosis – a pilot study
    Authors: Ljiljana Stojkovic, Aleksandra Stankovic, Ivan Zivotic, Evica Dincic, Dragan Alavantic, Maja Zivkovic
    Year: 2020

 

  • Title: The Effects of Aronia melanocarpa Juice Consumption on the mRNA Expression Profile in Peripheral Blood Mononuclear Cells in Subjects at Cardiovascular Risk
    Authors: Ljiljana Stojković, Ivan Jovanovic, Manja Zec, Ivan Zivotic, Ivan Zivotić, Jovana Kuveljić, Ana Kolaković, Ivana Kolić, Ana Djordjević, Marija Glibetić et al.
    Year: 2020

 

  • Title: CDKN2B gene expression is affected by 9p21.3 rs10757278 in CAD patients, six months after the MI
    Authors: Zivotić I, Djurić T, Stanković A, Milasinovic D, Stankovic G, Dekleva M, Marković Nikolić N, Alavantić D, Zivković M
    Year: 2019

 

  • Title: The HACD4 haplotype as a risk factor for atherosclerosis in males
    Authors: Zivotić I, Djurić T, Stanković A, Ivančević I, Končar I, Milasinovic D, Stankovic G, Alavantić D, Zivković M
    Year: 2018

 

  • Title: 9p21 locus rs10757278 is associated with advanced carotid atherosclerosis in a gender-specific manner
    Authors: Zivotić I, Djurić T, Stanković A, Djordjević A, Končar I, Davidović L, Alavantić D, Zivković M
    Year: 2016

 

  • Title: Genetic Variants in the Vicinity of LGALS-3 Gene and LGALS-3 mRNA Expression in Advanced Carotid Atherosclerosis: An Exploratory Study
    Authors: Djordjevic A, Zivkovic M, Stankovic A, Zivotic I, Koncar I, Davidovic L, Alavantic D, Djuric T
    Year: 2016

 

  • Title: The glutathione S-transferase T1 deletion is associated with susceptibility to multiple sclerosis
    Authors: Živković M, Životić I, Dinčić E, Stojković L, Vojinović S, Stanković A
    Year: 2013

 

✅ Conclusion

Dr. Životić exemplifies a new generation of biomedical scientists committed to bridging genetic science with clinical application. His work not only enhances the understanding of disease pathogenesis but also supports the advancement of personalized medicine. With a growing academic presence, a commitment to collaborative research, and a focus on translational impact, Dr. Životić is well-positioned to make lasting contributions to the global scientific community.

Liliana Elena Weimer | Clinical Neuroscience | Best Researcher Award

Published on by Neuroscientists

Dr. Liliana Elena Weimer | Clinical Neuroscience | Best Researcher Award

Dr.  Liliana Elena Weimer, Center For Global Health Istituto Superiore di Sanita’ Rome, Italy.

Dr. Liliana Elena Weimer is a highly accomplished physician and clinical researcher , where she has risen to the prestigious Level II “First Researcher” position. Her professional focus lies in clinical trials for infectious diseases, particularly HIV and Hepatitis C. She has played a critical role in major national and international research efforts, including collaborations with the U.S. Clinical Trials Group and leadership of the large-scale PITER cohort involving 25,000 HCV patients. She is known not only for her scientific contributions but also for her humanitarian efforts during the COVID-19 emergency. Among her recognitions is the 1st Prize at the 2019 International Congress on Hepatitis C in Seville. Throughout her career, she has exemplified scientific integrity, dedication, and service to public health.

Profile

Google Scholar

🎓 Early Academic Pursuits

Born on December 19, 1965, in Buenos Aires to Italian parents, Dr. Liliana Elena Weimer embraced her dual heritage and committed herself to a life in medicine and research. With Italian citizenship and deep academic determination, she laid the groundwork for her career by studying medicine, ultimately finding her professional home in Italy. Her academic path, though not fully detailed, clearly led her toward a focus on clinical medicine and infectious diseases, with her earliest professional roles marking the beginning of a lifelong engagement in public health and biomedical research. Her intellectual dedication and international roots later became an asset in global research collaborations.

🩺 Professional Endeavors

Dr. Weimer’s distinguished career spans over three decades at the Italian National Institute of Health (ISS), beginning in 1985. Starting as a dedicated clinical physician, she ascended to Level III researcher status by 1990 and continued to grow into higher ranks, culminating in her success in the national Art. 15 competition for the Level II “First Researcher” role in 2022, officially backdated to 2021. Throughout her tenure at ISS, she became a central figure within the Global Health Center in Rome. Known for her tireless commitment, she often described her career not simply as a job but as a “mission,” emphasizing both her personal and professional passion for making a difference in human health.

🧪 Contributions and Research Focus

Specializing in clinical trials, Dr. Weimer has coordinated and participated in numerous groundbreaking studies in HIV and Hepatitis C (HCV). Since the early 1990s, she has collaborated closely with renowned figures such as Prof. Giovanni Rossi, Prof. Stefano Vella, and Prof. Gianni Rezza, contributing to some of the most pivotal HIV antiretroviral therapy trials in history. Her research efforts extended to co-leading and organizing both national and international multicenter clinical trials. Notably, she has been at the forefront of the PITER study, a major nationwide cohort that follows 25,000 patients undergoing HCV treatment—one of the most comprehensive initiatives in Italy in the fight against hepatitis.

🌍 Global Collaborations and Humanitarian Engagement

Her impact extends beyond Italy, thanks to her active involvement with the U.S.-based American Clinical Trials Group on HIV studies. These collaborations have enhanced international understanding and treatment of HIV/AIDS. In addition to her clinical and research commitments, Dr. Weimer also devoted herself to frontline service during the COVID-19 pandemic. Volunteering both with the Civil Protection unit and at Bambino Gesù Children’s Hospital, she demonstrated profound humanitarian values. Her presence during a critical time underscored her belief in serving communities not just from behind a lab desk but also on the ground, directly supporting patients and health systems under strain.

🏅 Accolades and Recognition

Dr. Weimer’s work has been acknowledged at both national and international levels. One of the most prominent recognitions she received was the 1st Prize at the International Congress on Hepatitis C held in Seville in November 2019, a testament to her excellence and influence in the field of infectious disease research. Her achievements are not only measured in accolades but also in the tangible difference her work has made in advancing therapy options and clinical management of chronic viral diseases. Her rise within the ISS and the trust placed in her leadership of major research projects further affirm her standing within the scientific community.

💡 Impact and Influence

Over the course of her extensive career, Dr. Weimer has significantly shaped clinical research strategies in Italy, especially regarding chronic viral infections. Her coordination of thousands of patient cases within structured clinical trials has informed policy decisions and improved treatment protocols nationwide. Her presence at the ISS has also influenced future generations of researchers and clinicians, many of whom benefited from her mentorship, leadership, and example of scientific integrity. Through her rigorous methods and patient-focused approach, she has played a key role in Italy’s standing as a leader in global health research, especially in relation to HIV and HCV.

🔬 Legacy and Future Contributions

Looking forward, Dr. Weimer’s contributions will continue to echo through the fields of virology and clinical medicine. Her involvement in the PITER cohort and other studies has laid down essential groundwork for long-term epidemiological surveillance and patient care strategies. With her appointment as First Researcher, she enters a new chapter of leadership, likely to drive more innovative, patient-centered research initiatives in global health. Her legacy lies not only in her publications or awards but also in the thousands of lives improved by the treatments she helped to test, refine, and implement. The combination of scientific rigor and heartfelt service defines her enduring contribution to modern medicine.

Publication

  • Outcome of sustained virological responders with histologically advanced chronic hepatitis C – TR Morgan, MG Ghany, HY Kim, KK Snow, ML Shiffman, JL De Santo, … – 2010

 

  • Clinical, virologic, histologic, and biochemical outcomes after successful HCV therapy: a 5‐year follow‐up of 150 patients – SL George, BR Bacon, EM Brunt, KL Mihindukulasuriya, J Hoffmann, … – 2009

 

  • Safety and efficacy of simeprevir/sofosbuvir in hepatitis C–infected patients with compensated and decompensated cirrhosis – V Saxena, L Nyberg, M Pauly, A Dasgupta, A Nyberg, B Piasecki, … – 2015

 

  • Slow human immunodeficiency virus type 1 evolution in viral reservoirs in infants treated with effective antiretroviral therapy – D Persaud, SC Ray, J Kajdas, A Ahonkhai, GK Siberry, K Ferguson, … – 2007

 

  • Evaluation of proton pump inhibitor use on treatment outcomes with ledipasvir and sofosbuvir in a real‐world cohort study – EB Tapper, BR Bacon, MP Curry, DT Dieterich, SL Flamm, LE Guest, … – 2016

 

  • Microbial translocation is associated with residual viral replication in HAART-treated HIV+ subjects with< 50 copies/ml HIV-1 RNA – S Baroncelli, CM Galluzzo, MF Pirillo, MG Mancini, LE Weimer, … – 2009

 

  • Predictors of failure with high-flow nasal oxygen therapy in COVID-19 patients with acute respiratory failure: a multicenter observational study – R Mellado-Artigas, LE Mujica, ML Ruiz, BL Ferreyro, F Angriman, E Arruti, … – 2021

 

  • A randomized, double-blind trial on the use of a triple combination including nevirapine, a nonnucleoside reverse transcriptase HIV inhibitor, in antiretroviral-naive patients – M Floridia, R Bucciardini, D Ricciardulli, V Fragola, MF Pirillo, LE Weimer, … – 1999

 

  • Modeling cost‐effectiveness and health gains of a “universal” versus “prioritized” hepatitis C virus treatment policy in a real‐life cohort – LA Kondili, F Romano, FR Rolli, M Ruggeri, S Rosato, MR Brunetto, … – 2017

 

  • Real-life data on potential drug-drug interactions in patients with chronic hepatitis C viral infection undergoing antiviral therapy with interferon-free DAAs in the PITER network – LA Kondili, GB Gaeta, D Ieluzzi, AL Zignego, M Monti, A Gori, A Soria, … – 2017

 

🏁 Conclusion

Dr. Weimer stands as a distinguished figure in the field of global health research, with deep expertise in clinical trials and infectious diseases. Her legacy is marked by landmark contributions to HIV and HCV treatment protocols, influential collaborations, and compassionate public service. Her ongoing work continues to shape public health policy and medical research in Italy and beyond. As she advances in her leadership role at the ISS, her experience, insight, and dedication will remain vital to future innovations in clinical research and global health.

Rosario Osta | Molecular and Cellular Neuroscience | Best Researcher Award

Published on by Neuroscientists

Prof.Dr. Rosario Osta | Molecular and Cellular Neuroscience | Best Researcher Award

Prof. Dr. Rosario Osta, CIBERNED-Fundación Instituto de Investigación Sanitaria de Aragón-Universidad de Zaragoza,  Spain.

Prof. Rosario Osta Pinzolas is a distinguished geneticist and full professor at the University of Zaragoza, Spain. Her academic roots in veterinary sciences and a Ph.D. in Genetics laid the foundation for a prolific career in biomedical research, particularly in the fields of neuroscience and genetic disorders. With leadership roles in multiple high-profile research consortia such as CIBERNED, TRICALS, and ENCALS, she has established herself as a central figure in neurodegenerative disease research. Her scholarly output includes over 100 indexed publications, multiple national and international research projects, and an h-index exceeding 45.

Profile

Orcid 

Scopus

 

🎓 Early Academic Pursuits

Rosario Osta Pinzolas began her academic journey with a solid foundation in veterinary sciences, graduating as Licenciada en Veterinaria from the University of Zaragoza in 1989. Her academic inclinations quickly shifted toward molecular genetics, leading her to complete a Ph.D. in Genetics at the same university in 1994. Her early studies were driven by a deep curiosity about the mechanisms of heredity and gene expression, setting the tone for a lifelong commitment to biomedical research. These formative years cultivated her scientific rigor and sowed the seeds for a career that would eventually bridge basic science and translational medicine.

🧬 Professional Endeavors in Genetics and Biomedicine

Prof. Osta currently holds the esteemed title of Catedrática (Full Professor) in the Department of Anatomy, Embryology, and Genetics at the Faculty of Veterinary Medicine, University of Zaragoza. Since 2018, she has led her department with a focus on integrative biomedical sciences. She is the principal investigator of the LAGENBIO group recognized by both the Aragon Health Research Institute and the Government of Aragon. Under her leadership, the group has developed two major subprograms: TERAGEN and REGENERAGEN. As coordinator of the “Neuroscience and Mental Health Program” at IISA, she has spearheaded numerous efforts to understand and address neurological diseases through genetic approaches.

🧠 Contributions and Research Focus in Neuroscience

A prominent figure in neuroscience, Prof. Osta’s research lies at the intersection of genetics and neurodegeneration. She is currently the principal investigator of the only Aragon-based group within CIBERNED (Centro de Investigación Biomédica en Red sobre Enfermedades Neurodegenerativas), reflecting her national influence. Her team represents Zaragoza in prominent European consortia such as TRICALS and ENCALS, both focused on amyotrophic lateral sclerosis (ALS) and other motor neuron diseases. Through more than 100 indexed publications, predominantly in top-tier journals, her work delves into the molecular underpinnings of neurological disorders and explores regenerative medicine strategies, thereby contributing to innovative therapeutic avenues.

🧪 Accolades and Recognition in Scientific Excellence

Prof. Osta’s academic and research career has been punctuated by consistent recognition. She has completed five research productivity periods and one technology transfer period, acknowledged by CNEAI — a mark of sustained scientific impact. She has led over 74 research projects and contributed to more than 100 collaboration contracts, earning her four competitive research awards from respected institutions including CORIS, AREA, IIS, and SEBBM. Her contributions have been lauded not only for scientific quality but also for practical relevance in biomedical advancements.

🚀 Innovation and Impact in Translational Research

An ardent advocate for science with societal impact, Prof. Osta has significantly contributed to technology transfer. She holds nine patents, five of which have been licensed to industry partners. Her collaborations with companies have led to meaningful translational outputs, emphasizing her role in bridging the gap between academic research and real-world solutions. As former Director of the Technology Transfer and Innovation Secretariat at the University of Zaragoza for nearly a decade, she played a crucial role in institutional innovation strategies. Her involvement in joint university-company chairs and her role in the UZ Technology-Based Business Creation Committee for over 12 years further underscore her influence on academic entrepreneurship.

📚 Mentorship and Educational Leadership

Beyond the lab, Prof. Osta has left a profound mark as an educator and mentor. Since 2013, she has coordinated the Interuniversity Doctoral Program in Biomedical and Biotechnological Sciences, a joint initiative between the Universities of Zaragoza and La Rioja. Her mentorship includes the supervision of 13 Ph.D. theses — 9 of which earned international distinction and 6 received extraordinary doctoral awards. Her influence extends to guiding numerous undergraduate and master’s theses, fostering a new generation of scientists with a deep commitment to research excellence and innovation.

🌍 Legacy and Future Contributions

Prof. Rosario Osta’s legacy is defined by her ability to integrate scientific discovery, mentorship, and innovation. As a member of the Scientific Committee of the Luzón Foundation, her vision reaches beyond academia into public health advocacy and strategic research planning. With nearly 19,000 citations on Google Scholar and an h-index of 45, her work continues to inspire and inform global research communities. Her continued leadership in collaborative European projects ensures her contributions will shape the future of neuroscience, genetics, and translational medicine for years to come.

Publication

Title: Novel FKBP prolyl isomerase 1A (FKBP12) ligand promotes functional improvement in SOD1G93A amyotrophic lateral sclerosis (ALS) mice
Authors: L. Moreno-Martinez, N. Gaja-Capdevila, L. Mosqueira-Martín, R. Osta, F.J. Gil-Bea
Year: 2025

Title: Identifying Hub Genes and miRNAs Associated with Alzheimer’s Disease: A Bioinformatics Pathway to Novel Therapeutic Strategies
Authors: E. Gascón, A.C. Calvo, N. Molina, P. Zaragoza, R. Osta
Year: 2024

Title: Comparative Blood Profiling Based on ATR-FTIR Spectroscopy and Chemometrics for Differential Diagnosis of Patients with Amyotrophic Lateral Sclerosis—Pilot Study
Authors: K. Tkachenko, J.M. González Sáiz, A.C. Calvo, R. Osta, C. Pizarro Millán
Year: 2024

Title: Sex differences on constitutive long non-coding RNA expression: Modulatory effect of estradiol and testosterone in muscle cells
Authors: T. López-Royo, L. Moreno-Martinez, L. Moreno-García, R. Manzano, R. Osta
Year: 2024

Title: Differentially expressed lncRNAs in SOD1 G93A mice skeletal muscle: H19, Myhas and Neat1 as potential biomarkers in amyotrophic lateral sclerosis
Authors: T. López-Royo, L. Moreno-Martinez, P. Zaragoza, R. Manzano, R. Osta
Year: 2024

Title: Proteomic profiling of human plasma extracellular vesicles identifies PF4 and C1R as novel biomarker in sarcopenia
Authors: P. Aparicio, D. Navarrete-Villanueva, A. Gómez-Cabello, R. Osta, R. Manzano
Year: 2024

Title: Sporadic Amyotrophic Lateral Sclerosis Skeletal Muscle Transcriptome Analysis: A Comprehensive Examination of Differentially Expressed Genes
Authors: E. Gascón, P. Zaragoza, A.C. Calvo, R. Osta
Year: 2024

Title: Intermediate Repeat Expansion in the ATXN2 Gene as a Risk Factor in the ALS and FTD Spanish Population
Authors: D. Borrego-Hernández, J.F. Vázquez-Costa, R. Domínguez Rubio, M. Povedano, A. García-Redondo
Year: 2024

Title: New Insights into Endogenous Retrovirus-K Transcripts in Amyotrophic Lateral Sclerosis
Authors: L. Moreno-Martinez, S. Macías-Redondo, M.H.P. Strunk, R. Osta, J. Schoorlemmer
Year: 2024

Title: Analysis of Plasma-Derived Exosomal MicroRNAs as Potential Biomarkers for Canine Idiopathic Epilepsy
Authors: M. García-Gracia, L. Moreno-Martinez, A. Hernaiz, S. García-Belenguer, I. Martín-Burriel
Year: 2024

🏆 Conclusion

Based on her outstanding research contributions, innovation in translational science, mentorship record, and leadership within national and European research programs, Prof. Rosario Osta Pinzolas is an exceptionally strong candidate for the Best Researcher Award. Her profile reflects not only academic excellence but also societal impact and visionary leadership. While there is room for enhanced global outreach, her sustained achievements and contributions make her highly deserving of this prestigious recognition.

Mohamad-Reza Aghanoori | Neurodegenerative Disorders | Best Researcher Award

Published on by Neuroscientists

Dr. Mohamad-Reza Aghanoori | Neurodegenerative Disorders | Best Researcher Award

Dr. Mohamad-Reza Aghanoori, National Institute of Genetic Engineering and Biotechnology,  Iran.

Dr. Mohamad-Reza Aghanouri is a distinguished neuroscientist and molecular medicine expert whose academic journey spans Iran and Canada. Beginning with foundational training in genetics and human biology, he has advanced into a dynamic career focused on translational neuroscience, particularly the genetic regulation of neurodevelopmental and neurodegenerative disorders. His doctoral and postdoctoral research have contributed significant insights into insulin/IGF-1 signaling, mitochondrial function, and gene expression related to autism and diabetic neuropathy.

Profile

Google Scholar

🎓 Early Academic Pursuits

Mohamad-Reza Aghanouri embarked on his academic journey with a B.Sc. in Cellular and Molecular Biology–Genetics from Shahid Chamran University of Ahvaz, Iran, in 2009. His keen interest in the intricate mechanics of human biology led him to pursue an M.Sc. in Human Genetics at Shiraz University of Medical Sciences, where he explored non-invasive techniques for early sex determination through free fetal DNA analysis. His growing passion for neuroscience and genetics culminated in a Ph.D. from the University of Manitoba, Canada, where he studied at the Department of Pharmacology and Therapeutics and the Division of Neurodegenerative Disorders. His doctoral thesis, focused on insulin/IGF-1 regulation of mitochondrial function in diabetic neuropathy, laid a strong foundation for a dynamic career in translational neurogenetics.

🧬 Professional Endeavors in Translational Neuroscience

Dr. Aghanouri’s postdoctoral work reflects a robust engagement with translational neuroscience and molecular medicine. From 2019 to 2024, he served as a postdoctoral fellow at the Department of Medical Genetics, Cumming School of Medicine, University of Calgary, under the mentorship of Dr. Guang Yang. His research investigated translational regulation of genes implicated in brain development, especially in autism spectrum disorders and rare neurodevelopmental conditions. Prior to that, he worked with Prof. Paul Fernyhough in Winnipeg, Canada, where he examined the role of IGF-1 in ATP production in sensory neurons under diabetic stress conditions. His diverse experience also includes a pivotal R&D advisory role at Roya Bio Gene Company in Tehran, showcasing his versatility across both academic and industrial biosciences.

🔬 Contributions and Research Focus

Dr. Aghanouri’s research contributions bridge the realms of neurodevelopment, metabolism, and genetic regulation. He has delved into the complex interplay between growth factors like IGF-1 and mitochondrial dynamics, particularly in relation to diabetic neuropathy. At the University of Calgary, his postdoctoral investigations explored the molecular pathways influencing neurodevelopmental disorders, positioning his work at the intersection of genomics and neuroscience. His methodological expertise spans cellular models, gene expression analysis, and translational bioinformatics, underscoring a commitment to discovering mechanisms that translate molecular findings into therapeutic insights.

🏆 Accolades and Recognition

Over the course of his academic and research career, Dr. Aghanouri has amassed a commendable list of honors. He received the prestigious CIHR postdoctoral fellowship (CA$40,000 annually, plus research allowance), along with additional fellowships from the Alberta Children’s Hospital Research Institute and the Cumming School of Medicine. Notably, he clinched first place in the Striking Image Competition at the University of Calgary and was honored by the BoniadMelliNokhbegan Foundation for his exceptional research talent. He has also earned multiple research grants from Iranian institutions in 2023 and 2024, reflecting his cross-border research impact and trust among funding bodies.

📚 Institutional Leadership and Influence

In 2024, Dr. Aghanouri was appointed as the Head of the Library, Documentation, Scientometrics, and Publication Center at the National Institute of Genetic Engineering and Biotechnology (NIGEB) in Tehran. He also holds a faculty position in the Department of Molecular Medicine at NIGEB. These roles position him as a key academic leader in Iran’s scientific community, where he not only continues his research but also shapes institutional research strategies, publication ethics, and scientific communication infrastructures. His work contributes significantly to Iran’s national bioscience and health research priorities.

🌍 Impact and Global Engagement

With academic roots in Iran and a decade of research training in Canada, Dr. Aghanouri exemplifies international scientific collaboration. His work addresses global health concerns, such as diabetes-induced neuropathies and neurodevelopmental disorders like autism, thus resonating with both clinical and scientific audiences worldwide. Through his active participation in conferences, poster competitions, and collaborative projects, he serves as a bridge between Iranian biotechnology advancements and the international research community.

🔮 Legacy and Future Contributions

Looking ahead, Dr. Aghanouri is poised to further advance the fields of molecular neurogenetics and translational medicine. His ongoing research is expected to uncover novel genetic mechanisms underlying brain development and metabolic dysfunctions. As a faculty member and research leader, he is mentoring the next generation of Iranian scientists while enhancing the global understanding of complex neurological diseases. His integrated approach to research, policy, and education ensures that his legacy will be one of both scientific innovation and institutional transformation.

Publication

 

  • Betulin and its derivatives as novel compounds with different pharmacological effects
    S Amiri, S Dastghaib, M Ahmadi, P Mehrbod, F Khadem, H Behrouj, …
    2020

 

  • Oxidized phosphatidylcholines trigger ferroptosis in cardiomyocytes during ischemia-reperfusion injury
    A Stamenkovic, KA O’Hara, DC Nelson, TG Maddaford, AL Edel, …
    2021

 

  • Insulin-like growth factor-1 activates AMPK to augment mitochondrial function and correct neuronal metabolism in sensory neurons in type 1 diabetes
    MR Aghanoori, DR Smith, S Shariati-Ievari, A Ajisebutu, A Nguyen, …
    2019

 

  • The ER stress/UPR axis in chronic obstructive pulmonary disease and idiopathic pulmonary fibrosis
    M Aghaei, S Dastghaib, S Aftabi, MR Aghanoori, J Alizadeh, P Mokarram, …
    2020

 

  • MiRNA molecular profiles in human medical conditions: Connecting lung cancer and lung development phenomena
    MR Aghanoori, B Mirzaei, M Tavallaei
    2014

 

  • Mechanisms targeting the unfolded protein response in asthma
    S Dastghaib, PS Kumar, S Aftabi, G Damera, A Dalvand, A Sepanjnia, …
    2021

 

  • Nucleocytoplasmic transport of the RNA-binding protein CELF2 regulates neural stem cell fates
    MJ MacPherson, SL Erickson, D Kopp, P Wen, MR Aghanoori, S Kedia, …
    2021

 

  • CYP2E15B, CYP2E16, CYP2E17B, CYP2E12, and CYP2E1*3 Allele Frequencies in Iranian Populations
    GM Shahriary, H Galehdari, A Jalali, F Zanganeh, SMR Alavi, …
    2012

 

  • Insulin prevents aberrant mitochondrial phenotype in sensory neurons of type 1 diabetic rats
    MR Aghanoori, DR Smith, SR Chowdhury, MG Sabbir, NA Calcutt, …
    2017

 

  • CEBPβ regulation of endogenous IGF-1 in adult sensory neurons can be mobilized to overcome diabetes-induced deficits in bioenergetics and axonal outgrowth
    MR Aghanoori, P Agarwal, E Gauvin, RS Nagalingam, R Bonomo, …
    2022

✅ Conclusion

Dr. Aghanouri stands out as a versatile and impactful scientist whose contributions to neuroscience and genetic medicine hold promise for both understanding and treating complex neurological conditions. His career reflects a strong blend of academic excellence, international collaboration, and leadership in research development. As he continues to build bridges between Iranian and global biosciences, his future work is expected to leave a lasting legacy in molecular neuroscience and translational medicine.